GTBP GT Biopharma, Inc. - Common Stock
$0,28
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 14, 2026
52W-Spanne
$0–$1
1% of range
Analystenbewertung
BUY
7 analysts
Kursziel
$3
+979% upside
P/E (TTM)
-0.0
ROE
-645.4%
Nettogewinnmarge
—
GTBP Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$0.28
Marktkapitalisierung
$7M
P/E (TTM)
-0.0
EPS (TTM)
$-6.68
Umsatz (TTM)
—
Dividendenrendite
3.2%
ROE
-645.4%
Verschuldungsgrad
—
52W-Spanne
$0 – $1
GTBP Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
2019-12-31
→
2019-12-31
EPS
$-6.68
2018-12-31
→
2025-12-31
Freier Cashflow
—
2018-12-31
→
2019-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
GTBP
Peer-Median
P/E (TTM)
-0.0
—
P/B (K/B)
1.2
1.8
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
GTBP
Peer-Median
ROA
-456.3%
-102.4%
ROE
-645.4%
-82.4%
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
GTBP
Peer-Median
Current Ratio (Liquiditätsgrad)
3.5
5.9
Quick Ratio
2.9
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
GTBP
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
GTBP
Peer-Median
Payout Ratio (Ausschüttungsquote)
-0.81%
—
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
Dividendenrendite
3.2%
Ausschüttungsquote
-0.81%
5J Div CAGR
—
GTBP Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
7 Analysten
- Starker Kauf 2 28,6%
- Kauf 4 57,1%
- Halten 1 14,3%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
1 Analysten · 2026-08-16
Tief
$3.00
Hoch
$3.00
Median-Ziel
$3.00
+979,1%
Mittelwert-Ziel
$3.00
+979,1%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.77%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-0.11 | $-0.08 | -0.03% |
| 31. Dezember 2025 | $-4.84 | $-0.22 | -4.6% |
| 30. September 2025 | $-0.79 | $-0.39 | -0.40% |
| 30. Juni 2025 | $-0.52 | $-0.69 | 0.17% |
| 31. März 2025 | $-0.33 | $-0.65 | 0.32% |
| 31. Dezember 2024 | $-1.66 | $-1.58 | -0.08% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| GTBP | $20M | -0.1 | — | — | -645.4% | — |
| BCDA | $13M | — | -87.8% | — | 1660.5% | — |
| SNTI | — | -0.4 | -40.2% | — | — | — |
| AIXC | — | -0.3 | — | — | — | — |
| PDSB | — | -1.0 | — | — | — | — |
| INTS | $1M | -0.0 | — | — | -165.1% | — |
| PHIO | $12M | -0.2 | — | — | -57.5% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 17
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $0 | · | $0 | $0 | $27.0K | $61.0K | |
| Cost of Revenue | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $57.0K | |
| Gross Profit | · | · | · | · | · | · | · | · | $0 | $0 | $27.0K | $4.0K | |
| R&D Expense | $3M | $6M | $6M | $9M | $10M | $485.0K | $2M | $9M | $1M | $975.0K | $1M | $0 | |
| SG&A Expense | $9M | $9M | $7M | $12M | $48M | $6M | $10M | $12M | $135M | $8M | $8M | $2M | |
| Operating Expenses | · | · | $14M | $21M | $58M | · | $16M | $250M | $136M | $9M | $9M | $2M | |
| Operating Income | $-12M | $-14M | $-14M | $-21M | $-58M | $-7M | $16M | $-250M | $-136M | $-9M | $-9M | $-2M | |
| Interest Expense | · | · | $213.0K | $8.0K | $718.0K | $-3M | $-2M | $9M | $9M | $7M | $17M | $5M | |
| Other Non-op | $156.0K | · | $20.0K | · | $-498.0K | · | $23M | $-9M | $-9M | $19M | $-13M | $-21M | |
| Pretax Income | · | · | · | · | · | · | $-39M | $-259M | $-144M | $10M | $-21M | $-24M | |
| Income Tax | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-28M | $-13M | $-8M | $-21M | $-58M | $-28M | $-39M | $-259M | $-144M | $10M | $-21M | $-23M | |
| EPS (Basic) | $-6.68 | $-6.94 | $-5.64 | $-19.66 | $-2.06 | · | · | $-5.16 | $-8.60 | $119.91 | $-8.96 | · | |
| EPS (Diluted) | $-6.68 | $-6.94 | $-5.64 | $-19.66 | · | · | · | $-5.16 | $-8.60 | $119.91 | $-8.96 | · | |
| Shares (Basic) | 5,513,255 | 1,897,375 | 1,347,713 | 1,062,267 | 28,155,624 | · | · | 50,240 | 16,769 | 81,460 | 2,394,540 | · | |
| Shares (Diluted) | 5,513,255 | 1,897,375 | 1,347,713 | 1,062,267 | · | 4,385,222 | 3,383,941 | 50,240 | 16,769 | 81,460 | 2,394,540 | · | |
| EBITDA | $-12M | · | $-14M | $-21M | $-58M | $7M | $-16M | $-250M | $-136M | $-9M | · | $-2M |
Bilanz 22
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $4M | $1M | $6M | $9M | $5M | $28.0K | $60.0K | $576.0K | $19.0K | $47.0K | $855.0K | |
| Short-term Investments | · | · | $13M | $11M | $23M | · | · | · | · | · | · | · | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Inventory | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Prepaid Expense | $567.0K | $188.0K | $84.0K | $54.0K | $190.0K | $364.0K | $246.0K | $30.0K | $0 | $2.0K | $2.0K | $27.0K | |
| Current Assets | $8M | $4M | $14M | $17M | $32M | $6M | $274.0K | $90.0K | $576.0K | $21.0K | $49.0K | $882.0K | |
| PP&E (Net) | · | · | · | · | · | · | $0 | $35.0K | $6.0K | $4.0K | $5.0K | $6.0K | |
| Goodwill | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Intangibles | · | · | · | · | · | · | $0 | · | · | · | $0 | $0 | |
| Other Non-current Assets | · | · | · | · | · | · | $122.0K | · | · | · | · | · | |
| Total Assets | $8M | $4M | $14M | $17M | $32M | $6M | $396.0K | $25M | $254M | $25.0K | $54.0K | $888.0K | |
| Accounts Payable | $748.0K | $4M | $4M | $3M | $8M | $2M | $2M | $2M | $3M | $2M | $893.0K | $412.0K | |
| Accrued Liabilities | $2M | $2M | $1M | $2M | $2M | $1M | $2M | $1M | $102.0K | $219.0K | $4M | $3M | |
| Current Liabilities | $2M | $6M | $7M | $5M | $10M | $35M | $20M | $14M | $3M | $19M | $50M | $30M | |
| Capital Leases | · | · | · | $64.0K | · | · | · | · | · | · | · | · | |
| Total Liabilities | · | · | $7M | $5M | $10M | · | $20M | $14M | $3M | $19M | $51M | $30M | |
| Common Stock | $26.0K | $2.0K | $1.0K | $33.0K | $32.0K | $5.0K | $41.0K | $51.0K | $50.0K | $0 | $2.0K | $2.0K | |
| Paid-in Capital | $730M | $694M | $690M | $686M | $674M | $566M | $548M | $540M | $521M | $106M | $84M | $84M | |
| Retained Earnings | $-724M | $-695M | $-682M | $-674M | $-654M | $-596M | $-567M | $-529M | $-269M | $-125M | $-134M | $-113M | |
| Stockholders' Equity | $6M | $-2M | $7M | $12M | $22M | $-29M | $-19M | $11M | $252M | $-19M | $-51M | $-30M | |
| Liabilities + Equity | $8M | $4M | $14M | $17M | $32M | $6M | $396.0K | $25M | $254M | $25.0K | $54.0K | $888.0K | |
| Shares Outstanding | 25,534,173 | 2,234,328 | 1,380,633 | 1,090,748 | 32,061,989 | 5,218,122 | 4,104,982 | 50,650,478 | 50,117,977 | 104,218 | 2,400,000 | 2,366,588 |
Cashflow 12
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $432.0K | $230.0K | · | $8M | $34M | $269.0K | $5M | $10M | $130M | $7M | $4M | $3M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $22.0K | |
| Operating Cash Flow | $-13M | $-13M | $-9M | $-15M | $-16M | $-7M | $-4M | $-11M | $-5M | $-2M | $-5M | $-2M | |
| CapEx | · | · | · | · | · | · | $0 | $36.0K | $4.0K | $0 | $1.0K | $6.0K | |
| Investing Cash Flow | · | $13M | $-2M | $12M | $-23M | · | $200.0K | $-36.0K | $-4.0K | $0 | $-1.0K | $-6.0K | |
| Stock Issued | · | · | $6M | · | $25M | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | $6M | · | $25M | · | · | · | · | · | · | · | |
| Dividends Paid | $229.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $16M | $3M | $6M | $-224.0K | $42M | $13M | $3M | $10M | $6M | $2M | $4M | $3M | |
| Net Change in Cash | $3M | $3M | $-5M | $-3M | $4M | $5M | $-32.0K | $-516.0K | $557.0K | $-28.0K | $-808.0K | $812.0K | |
| Free Cash Flow | · | · | · | · | · | · | $-4M | $-11M | $-5M | $-2M | · | $-2M | |
| Levered FCF | · | · | · | · | · | · | $-6M | $-20M | $-14M | $-8M | · | $-7M |
Rentabilität 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | · | · | · | 6.6% | |
| Operating Margin | · | · | · | · | · | · | · | · | · | · | · | -3927.9% | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | · | -38506.6% | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | · | -38532.8% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | · | -3927.9% | |
| ROA | -456.3% | · | -49.3% | -85.4% | · | -934.3% | -299.7% | -185.3% | -112.6% | 24729.1% | · | -4538.9% | |
| ROE | -645.4% | · | -86.9% | -153.7% | -215.7% | 95.6% | 973.5% | -197.1% | -123.1% | -28.1% | · | 130.8% | |
| ROIC | · | · | · | · | · | · | 83.2% | -2199.4% | -53.9% | 49.5% | · | 8.1% |
Liquidität & Solvenz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | · | 2.1 | 3.4 | 3.1 | 0.2 | 0.0 | 0.0 | 0.2 | 0.0 | · | 0.0 | |
| Quick Ratio | 2.9 | · | 2.1 | 3.3 | 5.4 | 0.2 | 0.0 | 0.0 | 0.2 | 0.0 | · | 0.0 | |
| Interest Coverage | · | · | -63.7 | -2657.1 | · | -2.3 | -7.5 | -27.4 | -15.8 | -1.4 | · | -0.5 |
Effizienz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.0 | · | · | 0.0 | 0.0 | · | 0.1 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | · | · | · | 2.7 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | 3.0 |
Bewertung (TTM) 12
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $27.0K | $61.0K | |
| Net Income TTM | $-28M | $-13M | $-8M | $-21M | $-58M | $-28M | $-39M | $-259M | $-144M | $10M | $-21M | $-23M | |
| Market Cap | $20M | · | $11M | $870M | $2.93B | $1.13B | $2.88B | $16.79B | · | · | · | · | |
| P/E | -0.1 | -0.4 | -1.4 | -1.4 | · | · | 0.0 | -64.2 | · | · | · | · | |
| P/B | 3.5 | · | 1.4 | 74.1 | 133.9 | -38.3 | -149.3 | 1476.7 | · | · | · | · | |
| P / Tangible Book | 3.5 | · | 1.4 | 74.1 | 133.9 | · | · | · | · | · | · | · | |
| P / Cash Flow | -1.6 | · | -1.2 | -57.2 | -188.0 | -155.4 | -787.9 | -1572.6 | · | · | · | · | |
| P / FCF | · | · | · | · | · | · | -787.9 | -1567.3 | · | · | · | · | |
| Dividend Yield | 1.1% | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -851.0% | -227.5% | -73.7% | -74.0% | · | · | 121321646.1% | -1.6% | · | · | · | · | |
| Payout Ratio | -0.81% | · | · | · | · | · | · | · | · | · | · | · | |
| Annual Payout | $229.0K | · | · | · | · | · | · | · | · | · | · | · |
Gewinn- und Verlustrechnung 12
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $1M | $413.0K | $1M | $634.0K | $363.0K | $1M | $2M | $1M | $777.0K | $1M | $2M | $2M | $3M | $3M | |
| SG&A Expense | $3M | $2M | $4M | $3M | $1M | $833.0K | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $4M | |
| Operating Expenses | · | $2M | · | · | · | $488.0K | · | · | · | · | · | · | · | · | |
| Operating Income | $-5M | $-3M | $-6M | $-3M | $-2M | $-2M | $-4M | $-4M | $-3M | $-3M | $-4M | $-4M | $-6M | $-7M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | $1.0K | $212.0K | · | · | |
| Other Non-op | · | $15.0K | $0 | · | $156.0K | $1M | · | · | $27.0K | $-1M | $220.0K | · | · | $107.0K | |
| Net Income | $-5M | $-3M | $-6M | $8M | $-30M | $-776.0K | $-4M | $-3M | $-2M | $-3M | $-2M | $-227.0K | $-6M | $-7M | |
| EPS (Basic) | $-0.12 | $-0.11 | $3.53 | $1.04 | $-10.92 | $-0.33 | $-1.60 | $-1.53 | $-1.64 | $-3.61 | $-0.05 | $-0.21 | $-19.17 | $-0.22 | |
| EPS (Diluted) | $-0.12 | $-0.11 | $3.53 | $1.04 | $-10.92 | $-0.33 | $-1.60 | $-1.53 | $-1.64 | $-3.61 | $-0.05 | $-0.21 | · | · | |
| Shares (Basic) | 38,820,657 | 30,283,031 | -3,544,311 | 3,940,714 | 2,771,765 | 2,345,087 | -3,429,541 | 2,234,328 | 1,380,633 | -41,274,963 | 40,172,599 | 1,082,871 | -94,042,043 | 31,380,634 | |
| Shares (Diluted) | 38,820,657 | 30,283,031 | -3,544,311 | 3,940,714 | 2,771,765 | 2,345,087 | -3,429,541 | 2,234,328 | 1,380,633 | -41,274,963 | 40,172,599 | 1,082,871 | · | · | |
| EBITDA | $-5M | $-3M | · | $-3M | $-2M | $-2M | · | $-4M | $-3M | · | $-4M | $-4M | · | $-7M |
Bilanz 16
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $9M | $7M | $3M | $5M | $2M | $4M | $6M | $2M | $1M | $3M | $2M | $6M | $2M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $8M | $13M | $15M | $18M | $11M | $18M | |
| Prepaid Expense | $227.0K | $409.0K | $567.0K | $940.0K | $1M | $200.0K | $188.0K | $248.0K | $78.0K | $84.0K | $48.0K | $38.0K | $54.0K | $88.0K | |
| Current Assets | $6M | $10M | $8M | $4M | $7M | $3M | $4M | $7M | $10M | $14M | $18M | $20M | $17M | $21M | |
| Total Assets | · | · | $8M | $4M | $7M | · | $4M | $7M | $10M | $14M | $18M | $20M | $17M | $21M | |
| Accounts Payable | $1M | $253.0K | $748.0K | $769.0K | $1M | $2M | $4M | $3M | $3M | $4M | $4M | $3M | $3M | $3M | |
| Accrued Liabilities | $1M | $2M | $2M | $400.0K | $608.0K | $1M | $2M | $2M | $963.0K | $1M | $1M | $829.0K | $2M | $2M | |
| Current Liabilities | $2M | $2M | $2M | $1M | $31M | $4M | $6M | $5M | $5M | $7M | $5M | $4M | $5M | $5M | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | · | $31.0K | $64.0K | $92.0K | |
| Total Liabilities | · | · | · | $1M | $31M | · | · | · | $5M | · | $6M | $7M | $5M | $5M | |
| Common Stock | $45.0K | $35.0K | $26.0K | $6.0K | $3.0K | $3.0K | $2.0K | $2.0K | $1.0K | $1.0K | $41.0K | $37.0K | $33.0K | $33.0K | |
| Paid-in Capital | $735M | $734M | $730M | $721M | $700M | $695M | $694M | $694M | $690M | $690M | $688M | $688M | $686M | $685M | |
| Retained Earnings | $-731M | $-727M | $-724M | $-718M | $-726M | $-696M | $-695M | $-691M | $-684M | $-682M | $-677M | $-675M | $-674M | $-669M | |
| Stockholders' Equity | $4M | $8M | $6M | $3M | $-26M | $-980.0K | $-2M | $2M | $5M | $7M | $12M | $13M | $12M | $16M | |
| Liabilities + Equity | $6M | $10M | $8M | $4M | $7M | $3M | $4M | $7M | $10M | $14M | $18M | $20M | $17M | $21M | |
| Shares Outstanding | 44,668,969 | 35,181,891 | 25,534,173 | 6,051,874 | 3,272,995 | 2,536,397 | 2,234,328 | 2,234,328 | 1,380,633 | 1,380,633 | 40,639,688 | 36,882,724 | 1,090,748 | 32,507,618 |
Cashflow 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | · | $46.0K | $46.0K | $379.0K | $4.0K | $3.0K | $8.0K | $0 | $102.0K | · | · | · | · | · | |
| Operating Cash Flow | $-4M | $-2M | $-4M | $-4M | $-3M | $-2M | $-2M | $-3M | $-4M | $-2M | $-2M | $-3M | $-4M | $-3M | |
| Investing Cash Flow | · | · | · | · | · | · | $1.0K | $-1.0K | $5M | $478.0K | $3M | $-7M | $8M | $25.0K | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | $6M | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | $6M | · | · | |
| Dividends Paid | · | · | $144.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $297.0K | $5M | $8M | $977.0K | $6M | $616.0K | $0 | $0 | · | $0 | $0 | $6M | $-1.0K | $0 | |
| Net Change in Cash | $-4M | $2M | $4M | $-3M | $3M | $-2M | $-2M | $-3M | $871.0K | $-2M | $722.0K | $-4M | $3M | $-3M |
Rentabilität 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | · | · | · | 149.8% | -238.8% | · | · | -24.5% | -15.1% | · | -9.4% | -0.96% | · | -62.6% | |
| ROE | 40.5% | -85.9% | · | 325.6% | 427.6% | -35.8% | · | -37.8% | -24.7% | · | -14.6% | -1.5% | · | -28.8% |
Liquidität & Solvenz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.6 | 4.1 | · | 3.3 | 0.2 | 0.7 | · | 1.4 | 2.1 | · | 3.7 | 4.9 | · | 4.2 | |
| Quick Ratio | 2.2 | 3.7 | · | 1.9 | 0.2 | 0.7 | · | 1.4 | 2.1 | · | 3.7 | 4.9 | · | 4.1 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | -3621.0 | -17.3 | · | · |
Bewertung (TTM) 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-29M | $-25M | · | $-26M | $-38M | $-10M | · | $-12M | $-7M | · | $-12M | $-16M | · | $-21M | |
| Market Cap | $22M | $14M | · | $4M | $12M | $5M | · | $5M | $6M | · | $380M | $609M | · | $1.72B | |
| P/E | -0.0 | -0.0 | · | -0.1 | -0.2 | -0.4 | · | -0.3 | -1.2 | · | · | · | · | · | |
| P/B | 6.1 | 1.9 | · | 1.2 | -0.5 | -5.6 | · | 2.5 | 1.2 | · | 32.3 | 46.6 | · | 107.6 | |
| P / Tangible Book | 6.1 | 1.9 | · | 1.2 | · | · | · | 2.5 | 1.2 | · | 32.3 | 46.6 | · | 107.6 | |
| P / Cash Flow | · | -5.8 | · | · | · | -2.5 | · | · | -1.5 | · | · | -209.4 | · | · | |
| Earnings Yield | -2063.3% | -2529.4% | · | -2000.0% | -417.6% | -263.7% | · | -307.9% | -82.8% | · | · | · | · | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|
| Nettoergebnis | $-28M | — | — | $-13M | $-8M |
| Verwässerte EPS | $-6.68 | — | — | $-6.94 | $-5.64 |
Bilanz
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 3.5 | — | — | — | 2.1 |
| Quick Ratio | 2.9 | — | — | — | 2.1 |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 58 Einreicher · $898K gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 23 (+9 vs. Vorquartal) | 5 (-4 vs. Vorquartal) | 8 (+1 vs. Vorquartal) | 8 (+3 vs. Vorquartal) | +1.1M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $184.436 | 376.399 | 20,54% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $113.851 | 232.487 | 12,68% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $110.710 | 225.938 | 12,33% | Aktien |
| Everhart Financial Group, Inc. | $48.970 | 100.000 | 5,45% | Aktien |
| Arax Advisory Partners | $45.850 | 93.627 | 5,11% | Aktien |
| Opal Wealth Advisors, LLC | $40.063 | 81.811 | 4,46% | Aktien |
| NORTHERN TRUST CORP | $36.953 | 75.461 | 4,12% | Aktien |
| 49 WEALTH MANAGEMENT, LLC | $31.341 | 64.000 | 3,49% | Aktien |
| Cetera Investment Advisers | $27.392 | 55.936 | 3,05% | Aktien |
| SeaCrest Wealth Management, LLC | $24.534 | 50.100 | 2,73% | Aktien |
| KITCHING PARTNERS, LLC | $24.485 | 50.000 | 2,73% | Aktien |
| PNC Financial Services Group, Inc. | $19.600 | 40.000 | 2,18% | Aktien |
| Integrated Wealth Concepts LLC | $19.594 | 40.012 | 2,18% | Aktien |
| LPL Financial LLC | $17.815 | 36.379 | 1,98% | Aktien |
| MORGAN STANLEY | $11.054 | 22.573 | 1,23% | Aktien |
| Keel Point, LLC | $10.170 | 20.768 | 1,13% | Aktien |
| Corient Private Wealth LP | $10.000 | 20.000 | 1,11% | Aktien |
| Private Wealth Management Group, LLC | $9.794 | 20.000 | 1,09% | Aktien |
| SAGESPRING WEALTH PARTNERS, LLC | $9.794 | 20.000 | 1,09% | Aktien |
| StoneX Group Inc. | $8.667 | 23.258 | 0,97% | Aktien |
| Caitlin John, LLC | $8.080 | 16.500 | 0,90% | Aktien |
| Tempus Wealth Planning, LLC | $7.346 | 15.000 | 0,82% | Aktien |
| TWO SIGMA SECURITIES, LLC | $6.555 | 13.386 | 0,73% | Aktien |
| Prospera Financial Services Inc | $6.121 | 12.500 | 0,68% | Aktien |
| Verdence Capital Advisors LLC | $5.876 | 12.000 | 0,65% | Aktien |
| OSAIC HOLDINGS, INC. | $5.390 | 11.000 | 0,60% | Aktien |
| Mayflower Financial Advisors, LLC | $5.387 | 11.000 | 0,60% | Aktien |
| LaSalle St. Investment Advisors, LLC | $5.387 | 11.000 | 0,60% | Aktien |
| PARSONS CAPITAL MANAGEMENT INC/RI | $5.338 | 10.900 | 0,59% | Aktien |
| Koss-Olinger Consulting, LLC | $4.897 | 10.000 | 0,55% | Aktien |
| WELLS FARGO & COMPANY/MN | $4.897 | 10.000 | 0,55% | Aktien |
| BlackRock, Inc. | $4.070 | 8.312 | 0,45% | Aktien |
| ROYAL BANK OF CANADA | $4.000 | 7.600 | 0,45% | Aktien |
| HBK Sorce Advisory LLC | $3.175 | 10.000 | 0,35% | Aktien |
| Atlantic Union Bankshares Corp | $2.620 | 5.351 | 0,29% | Aktien |
| Allworth Financial LP | $2.205 | 4.501 | 0,25% | Aktien |
| NFSG Corp | $1.836 | 3.750 | 0,20% | Aktien |
| MassMutual Private Wealth & Trust, FSB | $1.469 | 3.000 | 0,16% | Aktien |
| Farther Finance Advisors, LLC | $1.469 | 3.000 | 0,16% | Aktien |
| West Financial Advisors, LLC | $1.225 | 2.500 | 0,14% | Aktien |
| Stone House Investment Management, LLC | $1.000 | 2.043 | 0,11% | Aktien |
| Tower Research Capital LLC (TRC) | $831 | 1.696 | 0,09% | Aktien |
| Triumph Capital Management | $810 | 1.655 | 0,09% | Aktien |
| BARCLAYS PLC | $706 | 1.441 | 0,08% | Aktien |
| JONES FINANCIAL COMPANIES LLLP | $645 | 1.500 | 0,07% | Aktien |
| MERCER GLOBAL ADVISORS INC /ADV | $490 | 1.000 | 0,05% | Aktien |
| Reyes Financial Architecture, Inc. | $306 | 625 | 0,03% | Aktien |
| HARBOUR INVESTMENTS, INC. | $245 | 500 | 0,03% | Aktien |
| Global Retirement Partners, LLC | $245 | 500 | 0,03% | Aktien |
| HRT FINANCIAL LP | $52 | 107.140 | 0,01% | Aktien |
| Hilltop National Bank | $49 | 100 | 0,01% | Aktien |
| IFG Advisory, LLC | $16 | 33 | 0,00% | Aktien |
| Coston, McIsaac & Partners | $8 | 17.092 | 0,00% | Aktien |
| AM INVESTMENT STRATEGIES LLC | $7 | 15.000 | 0,00% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $3 | 6 | 0,00% | Aktien |
| UBS Group AG | $1 | 2 | 0,00% | Aktien |
| JPMORGAN CHASE & CO | $0 | 1 | 0,00% | Aktien |
| SBI Securities Co., Ltd. | $0 | 1 | 0,00% | Aktien |
Unternehmensinsider 24 Insider · 9 Führungskräfte · 16 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Tony Cataldo | CEO | 2. Juni 2020 S | 6.500.000 | 0 | 0 | $0 |
| Raymond W. Urbanski | CEO | 1. Februar 2019 S | 1.351.918 | 0 | 0 | $0 |
| Marvin S Hausman MD | President & CEO | 6. November 2006 A | 2.404.080 | 0 | 0 | $0 |
| Steven T Guillen | President & CEO | 28. Dezember 2005 A | 600.000 | 0 | 0 | $0 |
| Gosse B Bruinsma | Chairman, Acting CEO | 12. Oktober 2004 A | — | 0 | 0 | $0 |
| Ray R Rogers | CEO/Chairman of the Board | 4. Dezember 2003 A | 1.677.988 | 0 | 0 | $0 |
| Michael D Centron | VP & CFO | 1. August 2006 A | — | 0 | 0 | $0 |
| Manus H Odonnell | Acting Chief Operating Officer | 24. Dezember 2004 A | — | 0 | 0 | $0 |
| Sharon Ellis | Chief Operational & Financial | 4. Dezember 2003 A | — | 0 | 0 | $0 |
| Anshuman Dube | Direktor | 23. Dezember 2010 C | 0 | 0 | 0 | $0 |
| Matthew R Spolar | Direktor | 9. November 2007 A | — | 0 | 0 | $0 |
| Sydney Colin Neill | Direktor | 9. November 2007 A | — | 0 | 0 | $0 |
| John E Repine | Direktor | 9. November 2007 A | 50.000 | 0 | 0 | $0 |
| Timothy C Rodell JR | Direktor | 28. Dezember 2005 A | — | 0 | 0 | $0 |
| Steven H Ferris | Direktor | 12. Oktober 2004 A | — | 0 | 0 | $0 |
| Gerard J M Vlak | Direktor | 12. Oktober 2004 A | — | 0 | 0 | $0 |
| Richard A Davis | Direktor | 22. Juni 2004 A | — | 0 | 0 | $0 |
| Ted Ford Webb | Direktor | 4. Dezember 2003 A | — | 0 | 0 | $0 |
| William G Pryor | Direktor | 4. Dezember 2003 A | — | 0 | 0 | $0 |
| Thomas M Wolf | Direktor | 30. Juni 2003 C | 78.500 | 0 | 0 | $0 |
| Bristol Investment Fund, Ltd. | 10%-Eigentümer | 5. April 2016 J | 463.806 | 0 | 0 | $0 |
| Theorem Group, LLC | 10%-Eigentümer | 23. Dezember 2010 C | 0 | 0 | 0 | $0 |
| Steven W Weldon | — | 22. Dezember 2020 S | 3.720.000 | 0 | 0 | $0 |
| Gary M Post | — | 31. August 2010 S | 900.000 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 5 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Theorem Group, LLC, Anshuman Dube ×3 Einreichungen | 26. Januar 2016 | — | Erste Einreichung | — | SEC |
| TorreyPines Therapeutics, Inc. (formerly Axonyx Inc.) | 6. Oktober 2008 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 10. März 2004 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 16. Januar 2004 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 22. März 2002 | — | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 1 ETF
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 376.399 SH | 8. August 2026 | Täglich |